RHUMBLINE ADVISERS - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 94 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$707
-79.5%
2,320
-52.5%
0.00%
Q2 2023$3,441
+6782.0%
4,888
-91.2%
0.00%
Q1 2023$50
-21.9%
55,477
+2.8%
0.00%
Q4 2022$64
-100.0%
53,990
-0.7%
0.00%
-100.0%
Q3 2022$409,000
+27.4%
54,367
+6.6%
0.00%
Q2 2022$321,000
+1.6%
51,020
+33.8%
0.00%
Q1 2022$316,000
+56.4%
38,130
-2.0%
0.00%
Q4 2021$202,000
-23.5%
38,905
-1.6%
0.00%
Q3 2021$264,000
-19.5%
39,540
+2.8%
0.00%
Q2 2021$328,000
+40.2%
38,461
+45.2%
0.00%
Q1 2021$234,000
-32.2%
26,487
-5.6%
0.00%
Q4 2020$345,000
+71.6%
28,067
+13.9%
0.00%
Q3 2020$201,000
-23.6%
24,637
-10.2%
0.00%
Q2 2020$263,000
+74.2%
27,437
+23.5%
0.00%
Q1 2020$151,000
-55.6%
22,221
-2.5%
0.00%
-100.0%
Q4 2019$340,000
+53.8%
22,799
+5.8%
0.00%
Q3 2019$221,000
-0.9%
21,556
+2.5%
0.00%
Q2 2019$223,00021,0370.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
P.A.W. CAPITAL CORP 540,000$4,482,0004.68%
Knoll Capital Management, LLC 694,232$5,762,0003.62%
Telemetry Investments, L.L.C. 213,000$1,768,0002.79%
ACT CAPITAL MANAGEMENT, LLC 250,000$2,075,0002.20%
VR Adviser, LLC 1,469,767$12,199,0001.98%
INTERWEST VENTURE MANAGEMENT CO 560,990$4,656,0001.78%
683 Capital Management, LLC 3,375,000$28,013,0001.50%
Trellus Management Company, LLC 300,000$2,490,0001.45%
Altium Capital Management LP 440,000$3,652,0001.22%
CAXTON CORP 116,884$970,0001.21%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders